Compare GoPro Inc (GPRO) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GoPro Inc vs ResMed Inc. — how do they compare? GoPro Inc trades at $0.62 (market cap $114.41M), while ResMed Inc. trades at $222.72 (market cap $32.61B). The key difference: ResMed Inc. is far larger — about 285× GoPro Inc's market cap, and ResMed Inc. pays a 1.17% dividend while GoPro Inc pays none. Which is the better fit depends on your goals.
| GPRO | RMD | |
|---|---|---|
Market Cap | $114.41M | $32.61B |
Sector | Technology | Health |
52-Week High | $2.88 | $293.73 |
52-Week Low | $0.62 | $182.82 |
Enterprise Value | $173.19M | $31.97B |
Dividend Yield | — | 1.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GoPro Inc
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
Read more on GPRO →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
